The efficacy of pectoral nerve block for breast surgery

Comparison of the efficacy of PECS II block in breast conserving surgery and sentinel lymph node biopsy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002509

Enrollment

Registered

2017-10-27

Start date

2016-07-14

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : Patients were randomly assigned into two groups and blinded to the allocation group. Propofol (2mg/kg) was administrated to induce anesthesia. After loss of consciousness, rocuroni

in 50&#37

oxygen and 2 to 2.5 ng/ml of effect-site remifentanil concentration to control proper blood pressure and heart rate. When patients wanted analgesics or analgesia was insufficient (numeric rating scale

4), fentanyl (0.4 µg/kg) were injected in the post-anesthetic care unit (PACU) after the operation. In the general ward, ketorolac 30mg (non-steroidal anti-inflammatory drug) was used to reduce postop

ropivacaine 10ml was administrated. Then the needle was advanced further until needle tip was located in the fascia plane between pectoralis minor and serratus anterior muscles, 0.25&#37

ropivacaine 20ml was administrated above serratus anterior muscles. All nerve blocks were performed by two anesthesiologist who were

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1) The patients with early breast cancer who would undergo breast conserving surgery and sentinel lymph node biopsy 2) All patients were from 20 years to 70 years 3) ASA physical status I and II 4) The patients who voluntarily agree with this clinical trial

Exclusion criteria

Exclusion criteria: 1) allergies to local anesthetics 2) anticoagulation use 3) serious neurological or psychiatric disorders 4) no co-operability 5) pregnancy and breastfeeding

Design outcomes

Primary

Measure	Time frame
the difference of postoperative opioid consumption between two groups during 24 hours postoperatively	—

Secondary

Measure	Time frame
Postoperative pain intensity at 0, 1/2, 1, 2, 6, 9, 18, 24 hours after end of surgery;Opioid requirements according to breast cancer location;Side effects of analgesics;Complications of the PECS II block	—

Countries

Korea, Republic of

Contacts

Public ContactDoo-Hwan Kim

Asan Medical Center

knaaddict@gmail.com+82-2-3010-1417

Outcome results